• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Spectroscopic and biochemical characterisation of self-aggregates formed by antitumor drugs of the camptothecin family: their possible role in the unique mode of drug action.

作者信息

Nabiev I, Fleury F, Kudelina I, Pommier Y, Charton F, Riou J F, Alix A J, Manfait M

机构信息

Laboratoire de Spectroscopie Biomoleculaire, UFR de Pharmacie, Universite de Reims Champagne-Ardenne, France.

出版信息

Biochem Pharmacol. 1998 Apr 15;55(8):1163-74. doi: 10.1016/s0006-2952(97)00508-x.

DOI:10.1016/s0006-2952(97)00508-x
PMID:9719470
Abstract

We describe the effect strongly influencing the biological activity of some camptothecin (CPT) drugs, the inhibitors of DNA topoisomerase I (topo I), namely, the formation of J-type aggregates in an aqueous buffer solution. These aggregates were built up under certain dilution conditions of the stock DMSO solutions of 20-S-camptothecin (20(S)CPT), 10,11-methylenedioxy-CPT (10,11-CPT) and 7-ethyl-10-hydroxy-CPT (SN38). The aggregates were found to be stereospecific, not being detectable for the 20(R)-stereoisomer of CPT. They were formed by the stacking interaction between quinoline rings of CPT chromophores with the inverse position of the nitrogen atoms. The aggregates were stable at acidic and neutral pHs, but dissociated at basic pHs. Self-aggregation prevented hydrolysis of the lactone ring at neutral pHs, thus preserving the drugs in a biologically active form. Addition of BSA did not induce either disaggregation or hydrolysis of the lactone ring, whereas the monomeric form of the drugs was shown to undergo rapid conversion to an inactive carboxylate form in the presence of human serum albumin [5]. The drugs did not form the aggregates in the presence of topo I. Moreover, rapid dissociation of the aggregates was observed if a self-aggregated drug solution was added to topo I alone or to the DNA-topo I cleavage assay. Neither DNA alone nor oligonucleotides derived from the sequences of the CPT-enhanced or topo I-induced cleavage sites in SV40 plasmid DNA induces changes in the aggregation state of the drugs. These observations are indicative of interaction between the aggregates and topo I. The aggregates were found to penetrate within the cells with much higher efficiency than a monomeric form of the drugs. Cellular uptake of aggregated and nonaggregated species correlated well with cytotoxic effects produced by the drug. In this manner, CPT's self-aggregation should be regarded as a favourable phenomenon producing species with a more stable biologically active structure of the lactone ring and exhibiting enhanced cellular uptake levels relative to the monomeric forms of medications.

摘要

相似文献

1
Spectroscopic and biochemical characterisation of self-aggregates formed by antitumor drugs of the camptothecin family: their possible role in the unique mode of drug action.
Biochem Pharmacol. 1998 Apr 15;55(8):1163-74. doi: 10.1016/s0006-2952(97)00508-x.
2
DNA topoisomerase I changes the mode of interaction between camptothecin drugs and DNA as probed by UV-resonance Raman spectroscopy.通过紫外共振拉曼光谱探测发现,DNA拓扑异构酶I改变了喜树碱类药物与DNA之间的相互作用模式。
FEBS Lett. 1996 Nov 4;396(2-3):289-92. doi: 10.1016/0014-5793(96)01118-0.
3
Quantitative analysis of DNA topoisomerase I activity in human and rat glioma: characterization and mechanism of resistance to antitopoisomerase chemical, camptothecin-11.人和大鼠神经胶质瘤中DNA拓扑异构酶I活性的定量分析:对拓扑异构酶化学药物喜树碱-11的抗性特征及机制
J Surg Oncol. 1993 Jun;53(2):97-103. doi: 10.1002/jso.2930530210.
4
Interactions of lactone, carboxylate and self-aggregated forms of camptothecin with human and bovine serum albumins.
FEBS Lett. 1997 Apr 7;406(1-2):151-6. doi: 10.1016/s0014-5793(97)00204-4.
5
Homocamptothecin, an E-ring-modified camptothecin analogue, generates new topoisomerase I-mediated DNA breaks.高喜树碱,一种E环修饰的喜树碱类似物,可产生新的拓扑异构酶I介导的DNA断裂。
Biochemistry. 1999 Nov 23;38(47):15556-63. doi: 10.1021/bi990947h.
6
Dual role of glutathione in modulating camptothecin activity: depletion potentiates activity, but conjugation enhances the stability of the topoisomerase I-DNA cleavage complex.谷胱甘肽在调节喜树碱活性中的双重作用:消耗增强活性,但结合作用增强拓扑异构酶I-DNA切割复合物的稳定性。
Mol Cancer Ther. 2001 Nov;1(1):11-20.
7
Determinants of drug response in camptothecin-11-resistant glioma cell lines.喜树碱-11耐药胶质瘤细胞系中药物反应的决定因素。
J Neurooncol. 1995;23(1):1-8. doi: 10.1007/BF01058453.
8
Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody.通过单克隆抗体测定喜树碱耐药肿瘤细胞系中DNA拓扑异构酶I的表达降低。
Cancer Res. 1990 Nov 1;50(21):6925-30.
9
Camptothecin and thiocamptothecin: the role of sulfur in shifting the hydrolysis equilibrium towards the closed lactone form.喜树碱和硫代喜树碱:硫在平衡移动中对形成闭环内酯形式的作用。
ChemMedChem. 2011 Sep 5;6(9):1706-14. doi: 10.1002/cmdc.201100206. Epub 2011 Jun 22.
10
Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties.高喜树碱是一种E环修饰的喜树碱,内酯稳定性增强,保留了靶向拓扑异构酶I的活性和抗肿瘤特性。
Cancer Res. 1999 Jun 15;59(12):2939-43.

引用本文的文献

1
Building Nanostructures with Drugs.用药物构建纳米结构
Nano Today. 2016 Feb;11(1):13-30. doi: 10.1016/j.nantod.2015.11.003.
2
Self-defensive nano-assemblies from camptothecin-based antitumor drugs.基于喜树碱类抗肿瘤药物的自防御纳米组装体。
Regen Biomater. 2015 Sep;2(3):159-66. doi: 10.1093/rb/rbv011. Epub 2015 Aug 10.
3
Synthesis and Self-Assembly of a Mikto-Arm Star Dual Drug Amphiphile Containing both Paclitaxel and Camptothecin.含紫杉醇和喜树碱的米克托臂星型双药两亲分子的合成与自组装
J Mater Chem B. 2014 Nov 14;2(42):7316-7326. doi: 10.1039/C4TB01084A.
4
Investigation of the mechanisms governing doxorubicin and irinotecan release from drug-eluting beads: mathematical modeling and experimental verification.从载药微球中释放阿霉素和伊立替康的机制研究:数学建模与实验验证。
J Mater Sci Mater Med. 2013 Oct;24(10):2359-70. doi: 10.1007/s10856-013-4992-4.
5
Potential oral delivery of 7-ethyl-10-hydroxy-camptothecin (SN-38) using poly(amidoamine) dendrimers.使用聚(酰胺 - 胺)树枝状大分子实现7 - 乙基 - 10 - 羟基喜树碱(SN - 38)的潜在口服给药。
Pharm Res. 2008 Jul;25(7):1723-9. doi: 10.1007/s11095-008-9572-9. Epub 2008 Apr 26.
6
Intra and inter-molecular interactions dictate the aggregation state of irinotecan co-encapsulated with floxuridine inside liposomes.分子内和分子间相互作用决定了与氟尿苷共同包裹在脂质体内的伊立替康的聚集状态。
Pharm Res. 2008 Jul;25(7):1702-13. doi: 10.1007/s11095-008-9561-z. Epub 2008 Mar 5.